Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Cancer Journal (Sudbury, Mass.)|April 25, 2006
Novel agents in acute myeloid leukemiaAhmed Aribi, Farhad Ravandi, Frank GilesExpert Opinion on Biological Therapy|December 23, 2025
Current status and future potential of CD123-based targeted therapies for acute leukemiaShukaib Arslan, Ahmed Aribi, Anthony Stein, et al.International Journal of Cancer|January 6, 2006
Loss of RAB25 expression in breast cancerJi-Ming Cheng, Ming Ding, Ahmed Aribi, et al.Cancer|January 16, 2007
Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemiaAhmed Aribi, Gautam Borthakur, Farhad Ravandi, et al.Cancer|September 2, 2006
Novel approaches in the treatment of systemic mastocytosisAlfonso Quintas-Cardama, Ahmed Aribi, Jorge Cortes, et al.Cancer|July 17, 2008
The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemiaAhmed Aribi, Hagop Kantarjian, Charles Koller, et al.Leukemia Research|October 19, 2006
T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 yearsAhmed Aribi, Yang Huh, Michael Keating, et al.Cancer|November 30, 2006
Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcomeHagop M Kantarjian, Susan O'Brien, Jianqin Shan, et al.Transplantation and Cellular Therapy|July 18, 2021
Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant RecipientsHaris Ali, Dat Ngo, Ahmed Aribi, et al.Stem Cell Research & Therapy|April 19, 2023
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective studyDat Ngo, Jason Chen, Jose Tinajero, et al.Pageof 7